Quick Answer
PANACEA LIFE SCIENCES HOLDINGS, INC. reported Operating Income Loss of -$5.55 million for the year ending 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +1.9% in Operating Income Loss from 2022 to 2023.
- This data is from PANACEA LIFE SCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
- XBRL data for this metric is available from 2014 to 2023 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$17.1 thousand | Q3 2014: -$74.9 thousand | Q1 2015: -$64.0 thousand | Q2 2015: -$102.4 thousand | Q3 2015: -$102.4 thousand | Q1 2016: -$233.4 thousand | Q2 2016: -$260.9 thousand | Q3 2016: -$359.8 thousand | Q1 2017: -$601.0 thousand | Q2 2017: -$506.3 thousand | Q3 2017: -$490.2 thousand | Q1 2018: -$1.38 million | Q2 2018: -$296.2 thousand | Q3 2018: -$425.9 thousand | Q1 2019: -$2.60 million | Q2 2019: -$2.02 million | Q3 2019: -$2.02 million | Q1 2020: -$2.63 million | Q2 2020: $845.4 thousand | Q3 2020: -$3.35 million | Q1 2021: -$1.09 million | Q2 2021: -$1.44 million | Q3 2021: -$1.26 million | Q1 2022: -$1.65 million | Q2 2022: -$1.24 million | Q3 2022: -$1.39 million | Q1 2023: -$1.29 million | Q2 2023: -$1.07 million | Q3 2023: -$1.41 million | Q1 2024: -$1.06 million.
- Over the full 10 years of available data (2014 to 2023), PANACEA LIFE SCIENCES HOLDINGS, INC.'s Operating Income Loss has declined by 1,219.7%.
- Historical annual values: Fiscal year 2023: -$5.55 million | Fiscal year 2022: -$5.65 million | Fiscal year 2021: -$5.94 million | Fiscal year 2020: -$5.26 million | Fiscal year 2019: -$10.67 million | Fiscal year 2018: -$2.44 million | Fiscal year 2017: -$3.12 million | Fiscal year 2016: -$1.60 million | Fiscal year 2015: -$389.3 thousand | Fiscal year 2014: -$420.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: